tiprankstipranks
Advertisement
Advertisement

HK:6160 Stock Latest News

BeOne Medicines price target raised to $367 from $364 at Leerink
The FlyBeOne Medicines price target raised to $367 from $364 at Leerink
8d ago
ONC
BeOne Wins First-in-Class U.S. FDA Nod for BCL2 Drug in Relapsed Mantle Cell Lymphoma
PremiumCompany Announcements
BeOne Wins First-in-Class U.S. FDA Nod for BCL2 Drug in Relapsed Mantle Cell Lymphoma
10d ago
6160
BeOne Medicines’ Beqalzi granted accelerated approval by FDA
PremiumThe Fly
BeOne Medicines’ Beqalzi granted accelerated approval by FDA
10d ago
ONC
BeOne Medicines Grants New RSUs to 201 Employees Under Equity Incentive Plan
PremiumCompany Announcements
BeOne Medicines Grants New RSUs to 201 Employees Under Equity Incentive Plan
10d ago
6160
BeOne Medicines price target raised to $395 from $389 at Morgan Stanley
PremiumThe Fly
BeOne Medicines price target raised to $395 from $389 at Morgan Stanley
16d ago
ONC
BeOne Medicines price target raised to $409 from $405 at Barclays
PremiumThe FlyBeOne Medicines price target raised to $409 from $405 at Barclays
16d ago
ONC
BeOne Medicines price target raised to $420 from $410 at Guggenheim
Premium
The Fly
BeOne Medicines price target raised to $420 from $410 at Guggenheim
16d ago
ONC
BeOne Medicines reports Q1 adjusted EPS $3.24 vs. $1.22 last year
Premium
The Fly
BeOne Medicines reports Q1 adjusted EPS $3.24 vs. $1.22 last year
16d ago
ONC
BeOne Medicines raises FY26 revenue view to $6.3B-$6.5B from $6.2B-$6.4B
PremiumThe Fly
BeOne Medicines raises FY26 revenue view to $6.3B-$6.5B from $6.2B-$6.4B
16d ago
ONC
BeOne Medicines Files U.S. Shelf Registration to Expand Capital Market Access
PremiumCompany Announcements
BeOne Medicines Files U.S. Shelf Registration to Expand Capital Market Access
17d ago
6160
BeOne Medicines Files Form S-3 to Expand U.S. Capital Market Access
PremiumCompany Announcements
BeOne Medicines Files Form S-3 to Expand U.S. Capital Market Access
17d ago
6160
BeOne Medicines Issues Q1 2026 Unaudited Results and Cautious Guidance
PremiumCompany Announcements
BeOne Medicines Issues Q1 2026 Unaudited Results and Cautious Guidance
17d ago
6160
BeOne Medicines Highlights Global Footprint With Latest Form 10-Q Filing
PremiumCompany AnnouncementsBeOne Medicines Highlights Global Footprint With Latest Form 10-Q Filing
17d ago
6160
AMD downgraded, Airbnb upgraded: Wall Street’s top analyst calls
Premium
The Fly
AMD downgraded, Airbnb upgraded: Wall Street’s top analyst calls
19d ago
AMD
BDX
BeOne Medicines initiated with an Overweight at Wells Fargo
Premium
The Fly
BeOne Medicines initiated with an Overweight at Wells Fargo
19d ago
ONC
BeOne Medicines: FDA grants Priority Review to sBLA for tevimbra/ziihera combo
PremiumThe Fly
BeOne Medicines: FDA grants Priority Review to sBLA for tevimbra/ziihera combo
24d ago
ONC
BeOne Medicines Posts U.S. Proxy Materials, Highlights Cross-Border Disclosure
PremiumCompany Announcements
BeOne Medicines Posts U.S. Proxy Materials, Highlights Cross-Border Disclosure
25d ago
6160
BeOne Medicines Sets 2026 AGM and Moves to Web-First Proxy Distribution
PremiumCompany Announcements
BeOne Medicines Sets 2026 AGM and Moves to Web-First Proxy Distribution
25d ago
6160
BeOne Medicines Sets Record Date for 2026 AGM to Define Voting Rights
PremiumCompany Announcements
BeOne Medicines Sets Record Date for 2026 AGM to Define Voting Rights
25d ago
6160
BeOne Medicines Sets May 6 Date for First‑Quarter 2026 Results and Investor Call
PremiumCompany AnnouncementsBeOne Medicines Sets May 6 Date for First‑Quarter 2026 Results and Investor Call
1M ago
6160
BeOne Medicines Revamps Board and Committees Ahead of 2026 AGM
Premium
Company Announcements
BeOne Medicines Revamps Board and Committees Ahead of 2026 AGM
1M ago
6160
BeOne Medicines price target lowered to $411 from $412 at Truist
Premium
The Fly
BeOne Medicines price target lowered to $411 from $412 at Truist
2M ago
ONC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >